You are here: Provider Connection Home » All Articles » Healthcare » Investigational Drug Study Leads to FDA Approval for Fenfluramine in Treatment for Dravet Syndrome

Investigational Drug Study Leads to FDA Approval for Fenfluramine in Treatment for Dravet Syndrome

Published on: September 11, 2020
Last updated: September 28, 2021

Dr. Mary Zupanc was a key investigator in a study that led to FDA approval for a medication to treat children with Dravet syndrome.

Link: https://care.choc.org/investigational-drug-study-leads-to-fda-approval-for-fenfluramine-in-treatment-for-dravet-syndrome/